UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer
UGN-301 was tolerated across all dose levels, with no dose-limiting toxicities or…
KAUST Professor Carlos Duarte Wins Prestigious Japan Prize for Pioneering Marine Science Research
Second time a KAUST scientist receives Japan Prize, making it the only…
Elizabeth Pike named Global Winner of the 2024 IOC Gender Equality, Diversity and Inclusion Champions Award
07 March 2025 - Professor Elizabeth Pike PhD, a leading expert in sport…
CQ Medical’s Iris AirShuttle Patient Transfer Platform Recognized at Women in Innovation Award Showcase
AVONDALE, Pa., March 5, 2025 /PRNewswire/ -- The Iris AirShuttle™, a patient transfer…
Hyundai Motor Group Partners with SOAS University of London to Nurture African Talent through New Scholarship Agreement
Hyundai Motor Group (the Group) partners with SOAS to foster a fundamental…
CEPT University Holds 19th Convocation, 644 Students Receive Degrees
AHMEDABAD, India, Jan. 18, 2025 /PRNewswire/ -- CEPT University celebrated its 19th…
CEPT University Holds 19th Convocation, 644 Students Receive Degrees
AHMEDABAD, India, Jan. 18, 2025 /PRNewswire/ -- CEPT University celebrated its 19th…
IIM Udaipur Hosts 8th JAAF – ATP India Symposium on January 11-12, 2025
UDAIPUR, India, Jan. 15, 2025 /PRNewswire/ -- The Indian Institute of Management…
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has…
Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
December 18, 2024 19:08 ET | Source: Mesoblast Limited RYONCIL (remestemcel-L) is…
